TNXP - This Biopharma Stock Is Trading 23% Higher In Pre-Market After Wrapping Up $4M Public Offering | Benzinga
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced the successful completion of its public offering. Following the announcement, the biopharmaceutical company’s shares soared, trading 22.94% higher in the pre-market on Friday.
What Happened: The public offering included 1,199,448 shares of common stock and pre-funded warrants to purchase up to 2,568,110 shares of common stock. The shares and warrants were priced at $1.065 and $1.064 respectively, with the warrants having an exercise price of $0.001 per share.
At the time of writing, it was trading at $1.34, according to Benzinga Pro.
See Also: Bitcoin, Ethereum, Dogecoin Slip Ahead Of Fed’s Interest Rate ...